登录

DoseMe实现独立健康系统的精确剂量

DoseMe Enables Precision Dosing at Independence Health System

businesswire | 2024-05-02 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System. This alliance will advance therapeutic drug monitoring and optimize pharmacogenetics integration into pharmacokinetic/pharmacodynamic (PK/PD) models as part of IHS’s precision dosing strategy and initiatives..

佛罗里达州朱庇特市(商业新闻短讯)--DoseMe是模型精确剂量(MIPD)软件的领先供应商,已宣布与Excela Health合作,Excela Health现已成为独立卫生系统的一部分。该联盟将推进治疗药物监测,并优化药物遗传学整合到药代动力学/药效学(PK/PD)模型中,作为IHS精确给药策略和举措的一部分。。

“DoseMe’s user friendly software is our preferred method of dosing as it takes away guess work and laborious time searching for updated records, freeing up our pharmacists to focus on what they do best,” said Robert Letterio, Pharmacy Supervisor at Independence. “The predictability is amazing and time savings for clinicians is anywhere from 25 – 30% per patient.

独立药房主管罗伯特·莱蒂奥(RobertLetterio)表示:“DoseMe的用户友好软件是我们首选的给药方法,因为它省去了猜测工作和搜索更新记录的费力时间,解放了我们的药剂师专注于他们做得最好的事情。”。“可预测性令人惊讶,临床医生的时间节省率为每位患者25%至30%。

We will continue to integrate new capabilities including AUC protocols with the incredible support of the DoseMe staff and extensive resource library.”.

我们将继续在DoseMe员工和广泛资源库的支持下,集成包括AUC协议在内的新功能。”。

Independence Health System offers patients nationally recognized quality care in cardiology, orthopedics, palliative care, and maternity as well as a broad range of surgical, medical, emergency, and behavioral health services, and an extensive network of primary care physicians. With five hospitals, nearly 1,000 healthcare providers and more than 7,000 employees, Independence Health System serves a ten county region and is the largest employer in Butler and Westmoreland counties..

独立健康系统为患者提供全国公认的心脏病学、骨科、姑息治疗和产科优质护理,以及广泛的外科、医疗、急诊和行为健康服务,以及广泛的初级保健医生网络。独立医疗系统拥有五家医院、近1000家医疗保健提供者和7000多名员工,服务于十个县的地区,是巴特勒县和威斯特摩兰县最大的雇主。。

Dr. Sharmeen Roy, PharmD, BCPS, Chief Strategy and Science Officer, remarks on the partnership: “IHS’s commitment to excellence aligns perfectly with DoseMe’s vision. Our joint effort in precision dosing is set to decrease adverse drug events and cut healthcare costs significantly – key objectives in our shared agenda to enhance patient outcomes.”.

首席战略和科学官、BCPS医学博士Sharmeen Roy博士对该合作关系发表评论:“IHS对卓越的承诺与DoseMe的愿景完全一致。我们在精确给药方面的共同努力旨在减少药物不良事件并大幅降低医疗保健成本,这是我们共同议程中提高患者预后的关键目标。”。

Looking forward, DoseMe’s innovative solutions will be fundamental for modern medicine, offering unprecedented accuracy in medication management. For more information on precision dosing models offered by DoseMe, visit https://doseme-rx.com/why-dosemerx/drug-packages

展望未来,DoseMe的创新解决方案将成为现代医学的基础,为药物管理提供前所未有的准确性。有关DoseMe提供的精确剂量模型的更多信息,请访问https://doseme-rx.com/why-dosemerx/drug-packages

About DoseMe

关于DoseMe

DoseMe combines smart technology with science, leveraging clinically validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified.

DoseMe将智能技术与科学相结合,利用临床验证的PK/PD模型,患者特征,药物浓度和基因型,在几秒钟内准确地个性化剂量。该平台符合HIPAA、ISO和FDA标准,是唯一获得HITRUST CSF认证的贝叶斯给药平台。

For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories.

有关其产品Dosemex和DoseMe Analytics成功应用的更多信息,请访问https://doseme-rx.com/success-stories.

推荐阅读

Dameron医院选择DoseMeRx推进精确给药

businesswire 2024-05-13 19:00

随着澳大利亚一流医院和癌症中心继续采用贝叶斯配药法,DoseMe的全球足迹不断扩大

businesswire 2024-04-17 18:59

智能给药平台研发商DoseMe与Albertina icome Praha达成合作,以进军捷克和斯洛伐克市场

businesswire 2024-03-05 20:59

businesswire

6562篇

最近内容 查看更多

Mirum Pharmaceuticals的LIVMARLI数据在ESPGHAN年会上展示

5 小时后

Oak Hill Bio和Chiesi Group宣布第一名患者参与恢复的2b期临床研究,评估OHB-607预防支气管肺发育不良,支气管肺发育异常是早产儿慢性肺病的最常见原因

15 小时前

Whitefort Capital发布致Arbutus Biopharma股东的公开信,概述实现价值最大化的途径

17 小时前

相关公司查看更多

DoseMe

智能给药平台研发商

立即沟通

Excela Health

医疗卫生系统

立即沟通

产业链接查看更多

所属赛道

化学制药
近30天,融资5起 过亿美元融资3起
综合性医院
医疗信息化
近30天,融资13起
在国民爱牙意识增强、口腔诊疗需求扩大、国民收入快速增长、民营口腔医疗机构持续发力等因素的驱动下,预计未来口腔医疗服务市场将持续快速扩张,有望于2026年突破3千亿元,达到约3182亿元。预计2022年到2026年的复合增长率将达到15.6%。